₹710
*Average Price as per 7 May, 2024
Fundamentals
FACE VALUE
10
BOOK VALUE
1270.79
NO OF SHARES
22958222
EPS
114
SALES
3036.92
INDUSTRY PE
30
DIVIDEND
10
DIVIDEND YIELD
1.18
PE
7.41
PB
0.66
PS
0.64
MARKET CAP
1939.97
EQUITY
21.35
PAT
241
MESSAGE
2022-23
OVERVIEW
Agrochemicals
The Agrochemicals business follows the ‘Crop Care Concept’, which ensures the safety and health of crops by identifying the problems affecting them and procuring the right solutions. A number of products categories such as Insecticides, Herbicides, Bactericides, Acaricides, Plant Growth Regulators and Surfactants are manufactured under the division’s scope of offerings.
Indofil is committed to excellence in product quality and service. The Company's focus is to ensure the well-being of farmers by protecting their crops and facilitating better yields. The division is supported by talented agricultural graduates and doctorates and a strong marketing, technical, sales and logistics group. The Company's productivity improvement programme is designed to educate farmers through demonstrations for effective and economic ways of crop protection.
With the basic objective of improving the efficiency and agility of field development assistants and optimising demand generation activities,
Indofil is ready to launch a unique in-house mobile application – Ujjwal Kheti - this year. The app will enhance farmer engagement and also prescribe methods for better crop yields.
Indofil Innovative Solutions Division
The Indofil Innovative Solutions (IIS) division caters to small, medium and large industrial manufacturers globally. Through a network of regional offices and stock points at major centres, and by leveraging technical capability, Indofil delivers the benefits of the company's chemicals to customers.
With state-of-the-art technologies and strong brand equity, the company emerged as the leading manufacturer and supplier in the industry. This, coupled with in-house product development and application know-how, delivered significant growth for dispersants, re-dispersible polymer powder and impact modifiers. It have enhanced manufacturing capability with a new unit at Dahej. Along with a highly qualified and well-experienced sales team, application technology teams are working closely with customers in the leather, coating, textile and plastics industries. During the year, the company entered into a joint venture with Italy-based Reagens the world’s leading Polyvinyl Chloride (PVC) heat stabilisers additives manufacturing company.
Manufacturing Facilities.
Indofil has four manufacturing facilities producing multi products with the state-of-the-art PLC (Programmable Logic Control) and DCS (Distributed Control System) based systems and multiple toll manufacturing units across various parts of India. The first plant of Indofil at Thane, Maharashtra state commissioned in 1962 to produce various fungicides including Mancozeb, Zineb, Maneb, Cymoxanil, Tricyclazole, Myclobutanil, Metalaxyl, Dodine and Propergite. Indofil expanded its manufacturing facilities in Gujarat state by adding Mancozeb mixtures and new fungicide molecules by commissioning 2 manufacturing plants at Dahej, SEZ (Special Economic Zone, ranked among the top 10 SEZs in the world by Financial Times, London) and 1 manufacturing unit at Dahej, GIDC location. The increased production capacity has helped Indofil in reducing the process cost. In recent times, the finding of large chemical cluster at dahej may provide aid to Indofil Industries Ltd.
INSIGHT
Indofil Industries holds 65.45 Lakh shares of Godfrey Philips India Limited (CMP – Rs 3209/sh).
Total Investment Value as on April 04, 2024 stands at Rs 2094.40 Cr.
Intrinsic Worth of Indofil Industries Ltd per share - Rs 912 considering only Godfrey Philips India Limited's holding.
Financial Insight
Particulars | FY21 | FY22 | FY23 |
Revenue | 2430.78 | 2795.09 | 3036.92 |
Revenue Growth | 10% | 15% | 9% |
EBITDA | 456.51 | 356.48 | 378.87 |
EBIT | 354.81 | 341.64 | 340.85 |
PAT | 66.82 | 218.83 | 241.14 |
The Group’s Consolidated Income was up from Rs. 2,795 Crores to Rs. 3036.92 Crores in the year under review, increasing by 9 % y-o-y.
The Consolidated Earning Before Interest and Tax for the year stood at Rs. 340.85 Crores against Rs. 341 Crores for the Previous Year - a decrease of 0.30% y-o-y.
The increase in sales and profits can be attributed to positive factors that has impacted Company and its business. One of the important factor was reduction in finance costs as a result of pre payment of loans and reduced borrowings in the books (both short-term and long-term).
Directors recommend for approval of the Company’s Shareholders at the ensuing Annual General Meeting (AGM), a final Dividend for the year ended March 31, 2023, i.e. Rs. 10/- for each Fully Paid Up Equity Shares of Rs. 10 each and Rs. 3/- for each Partly Paid Up Equity Shares of Rs. 3 each.
SECONDARY NAME
ISIN
CDSL
NSDL
INDUSTRY
SECTOR (READ ONLY)
SHARE HOLDINGS
Name of Shareholder | Holdings |
---|---|
K.K. Modi Investment & Financial Services Private Limited | 44.75 % |
UPSIDC LIMITED | 9.45 % |
APMS Investment Fund Ltd | 7.12 % |
Modi Industries Limite | 4.57 % |
Cresta Funds Ltd. | 2.17 % |
Life Insurance Corporation of India | 1.3 % |
We're different. SB NRI is the first of it's kind platform built for NRIs offering digital Investment plans.
Schedule a CallTrusted by 1,000s of NRIs spread across the Globe